EndoBarrier eliminates or reduces insulin therapy in Australian patients: The EndoBarrier is an alternative to Bariatric surgery in patients who need to achieve resolution of Type 2 diabetes and/or get back to a healthy weight. It is a flexible intestinal liner (like a windsock) that prevents absorption of fats and sugars in the upper small bowel. It does not require surgery, as it is inserted with an endoscopy as day surgery, and stays in place for one year, after which it is removed, again endoscopically. Bariatric News yesterday that EndoBarrier resulted in a rapid reduction in, and elimination of, insulin therapy by patients with type 2 diabetes and obesity, according to findings from 100 Australian patients. Prof. Reg Lord, form St. Vincents Hospital in Sydney presented at the American Association for Clinical Endocrinology 23rd Annual Meeting and Scientific Congress in Las Vegas. He said that “While based on a small number of patients, these findings show that EndoBarrier Therapy has a real, immediate impact on glycaemic levels... We are pleased that EndoBarrier Therapy offers the opportunity for patients to reduce their reliance on insulin, which is often viewed as a last resort treatment for diabetes. We view EndoBarrier Therapy as a non-surgical treatment option that possibly extends the utility of their existing pharmaceutical treatment regimens.” This research looked at the outcomes of the first 100 patients in Australia who received EndoBarrier Therapy. Of these 100 patients, 11 were using insulin to manage their type 2 diabetes prior to receiving EndoBarrier Therapy. Following placement of the EndoBarrier, 54% of the patients were able to completely cease use of insulin. The remaining patients were also able to decrease their insulin injection frequency, daily dosage or both. This reduction in insulin use was accompanied by a lowering of HbA1c to 7.3%, from a HbA1c of 8.8% at baseline. The research also demonstrated the positive effects of EndoBarrier Therapy on weight; patients achieved a median weight loss of 11.1kg. bariatricnews.net/?q=news/111468/endobarrier-eliminates-or-reduces-insulin-therapy
Posted on: Tue, 20 May 2014 00:51:09 +0000
Trending Topics
Recently Viewed Topics
© 2015